Gabriel J. LaBonia

Drug penetration and metabolism in 3D cell cultures treated in a 3D printed fluidic device: assessment of irinotecan via MALDI imaging mass spectrometry

Gabriel J. LaBonia, Sarah Y. Lockwood, Andrew A. Heller et al. · PROTEOMICS · 2016 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

iTRAQ Quantitative Proteomic Profiling and MALDI–MSI of Colon Cancer Spheroids Treated with Combination Chemotherapies in a 3D Printed Fluidic Device

Gabriel J. LaBonia, Katelyn R. Ludwig, C. Bruce Mousseau et al. · Analytical Chemistry · 2017 · 41 citations

Medicine, Oncology, Pharmacology +17

Glucose Restriction Combined with Autophagy Inhibition and Chemotherapy in HCT 116 Spheroids Decreases Cell Clonogenicity and Viability Regulated by Tumor Suppressor Genes

Monica M. Schroll, Gabriel J. LaBonia, Katelyn R. Ludwig et al. · Journal of Proteome Research · 2017 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Assessing chemotherapeutic effectiveness using a paper-based tumor model

Matthew W. Boyce, Gabriel J. LaBonia, Amanda B. Hummon et al. · The Analyst · 2017 · 34 citations

Medicine, Cancer Biology, Oncology +17

Developing a Drug Screening Platform: MALDI-Mass Spectrometry Imaging of Paper-Based Cultures

Fernando Tobias, Julie C. McIntosh, Gabriel J. LaBonia et al. · Analytical Chemistry · 2019 · 32 citations · Full text

Pharmacy, Bioengineering, Pharmacology +17